Revathi Naadimuthu, MD
Ophthalmology · Freehold, NJNPI 1295993731
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.2% of the total across 332 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. Among ophthalmology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 332 payments — averaging $35.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$3K
- Sight Sciences, Inc.$2K
- Bausch & Lomb Americas Inc.$2K
- Glaukos Corporation$1K
- AbbVie$1K
- Alcon$806
- plus $3K from 20 others
What the payments were for
- Grants$6906%
- Food & beverage$11,19694%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 42 | $2,593 |
| Sight Sciences, Inc. | 21 | $1,902 |
| Bausch & Lomb Americas Inc. | 55 | $1,601 |
| Glaukos Corporation | 12 | $1,147 |
| AbbVie(2 entities) | 41 | $1,134 |
| Alcon | 23 | $806 |
| Sun Pharmaceutical Industries Inc. | 37 | $622 |
| Dompe US, Inc. | 10 | $275 |
| Kala Pharmaceuticals, Inc. | 11 | $214 |
| Ocular Therapeutix, Inc. | 6 | $213 |
| Rxsight Inc | 1 | $179 |
| Tarsus Pharmaceuticals, Inc. | 10 | $179 |
| Oyster Point Pharma, Inc. | 11 | $178 |
| Novartis | 13 | $176 |
| Biotissue Holdings Inc. | 9 | $139 |
| Apellis Pharmaceuticals, Inc. | 1 | $99 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 6 | $85 |
| Eyepoint US, Inc. | 5 | $69 |
| Rayner Intraocular Lenses Limited | 4 | $67 |
| Shire North American Group Inc | 4 | $53 |
| Thea Pharma Inc. | 2 | $41 |
| Mallinckrodt Hospital Products Inc. | 2 | $31 |
| Eyevance Pharmaceuticals LLC | 2 | $27 |
| NEW World Medical,inc. | 2 | $22 |
| ANI Pharmaceuticals, Inc. | 1 | $17 |
| Harrow Eye, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OMNI(R) SURGICAL SYSTEM (US)$1,678
- Tecnis IOL$595
- STELLARIS$569
- CATALYS SYSTEM$393
- enVista MX60 IOL$388
- Tecnis Simplicity$352
- DURYSTA$345
- VUITY$345
- XEN GLAUCOMA TREATMENT SYSTEM$345
- iDoseTR$298
- enVista Aspire IOL$262
- RXSIGHT CONTACT LENS$179
- RXSIGHT INJECTOR CARTRIDGE$179
- RXSIGHT INJECTOR HANDPIECE$179
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$179
- LIGHT ADJUSTABLE LENS (LAL)$179
- iDose$166
- ENVISTA ENVY IOL$146
- ScoutPro Osmolarity System$146
- ARGOS$139
How this compares
$11,886 in reported general payments places this provider in the 90th percentile of 583 ophthalmology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxervateCenegermin-Bkbj | 16 | $443,927 |
| RestasisCyclosporine | 72 | $72,212 |
| CequaCyclosporine | 32 | $37,202 |
| XiidraLifitegrast | 27 | $36,427 |
| Prednisolone Acetate | 860 | $29,092 |
| Cyclosporine | 33 | $20,192 |
| VyzultaLatanoprostene Bunod | 34 | $16,656 |
| LumiganBimatoprost | 31 | $15,890 |
| MieboPerfluorohexyloctane/Pf | 17 | $14,344 |
| MoxifloxacinMoxifloxacin Hcl | 609 | $12,973 |
| Difluprednate | 67 | $6,358 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 31 | $6,159 |
| Brimonidine Tartrate | 54 | $5,652 |
| Diclofenac Sodium | 429 | $4,277 |
| Travoprost | 17 | $4,166 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Dompe US, Inc.Oxervate | $275 | $443,92716 claims |
| AbbVieRestasis, Lumigan | $1,134 | $88,102103 claims |
| Bausch & Lomb Americas Inc.Xiidra, Vyzulta, Miebo | $1,601 | $67,42778 claims |
| Sun Pharmaceutical Industries Inc.Cequa | $622 | $37,20232 claims |
| AlconSimbrinza | $806 | $6,15931 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate | $85 | $3,73718 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 583 ophthalmology providers in New Jersey.
Other ophthalmology in Freehold
- Rajen DesaiFreehold$311K
- Alain BauzaFreehold$58K
- Eric GershenbaumFreehold$23K
- Jai ParekhWoodland Park$2M
- Sharad MansukaniMoorestown$744K
- Ravi PatelEatontown$729K
- Cynthia MatossianPennington$655K
- Eric MannDover$604K
- Brett BieloryRutherford$477K
- Albert KhouriNewark$428K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.